Leslee J. Shaw

TL;DR: The field of noninvasive imaging for ischemic heart disease (IHD) has been transformed by an increasing amount of high-quality evidence to support newer imaging technology, such as coronary computed tomography (CT) angiography, and to support new drug discovery techniques.

TL;DR: This observation of improved population safety from the PROTECTION VI trial should prompt a shift in healthcare policies to limit higher exposures and provide broader support for imaging techniques capable of aggressive reduction in doses, such as is achievable with CT or PET imaging.

TL;DR: Advances in technology have continuously helped to clarify etiology and mechanisms of disease in patients originally classified as “idiopathic” and imaging, particularly cardiac magnetic resonance (CMR), has been especially effective in identifying unique diagnostic tissue.

TL;DR: This consensus document was devised from an expert panel meeting of the International Atomic Energy Agency, highlighting available evidence with a focus on the utility of stress myocardial perfusion imaging in post-STEMI patients to serve as guidance to the prudent and appropriate use of nuclear imaging for targeting therapeutic management and avoiding unnecessary invasive procedures within Latin American and Caribbean countries.

TL;DR: In this study, PET yielded the highest overall diagnostic accuracy, which was greater than CTA or SPECT, and the authors used state-of-the-art advanced imaging techniques, including measurements of coronary flow reserve with PET and hybrid PET and SPECT-CTA.